Intel HPC Server Demo: Clinical Trial Patient Screening via Genome Analysis | Intel Business

Опубликовано 24 февраля 2017, 17:13

QIAGEN*, powered by the Intel® Scalable System Framework and managed by the Intel® HPC Orchestrator, performs genome sequencing and analyzes the sequenced DNA to help identify patients who have variants of interest compared to a reference genome, and thus could have the protein that the cryo-EM and LAMMPS output have identified as being of interest. By speeding the identification of patients who have the right protein and thus meet the criteria for a clinical trial, this analysis can speed an important aspect of clinical trials, reduce trial costs, and lead to more effective targeted treatments with fewer undesirable side effects.

Subscribe now to Intel Business on YouTube: intel.ly/43XZh6J

About Intel Business:
Get all the IT info you need, right here. From data centers to devices, the Intel® Business Center has the resources, guidance, and expert insights you need to get your IT projects done right.

Connect with Intel Business:
Visit Intel Business's WEBSITE: intel.ly/itcenter
Follow Intel Business on TWITTER: twitter.com/IntelBusiness
Follow Intel Business on LINKEDIN: linkedin.com/showcase/intel-bu...
Follow Intel Business on FACEBOOK: facebook.com/IntelBusiness

Intel HPC Server Demo: Clinical Trial Patient Screening via Genome Analysis | Intel Business
youtube.com/intelbusiness